EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A branched peptide targets virus and host to block influenza virus and rhinovirus entry

Xinjie Meng, Chuyuan Zhang, Xiankun Wang, Jilong Shi, Zixian Song, Purui Ke, Yao Chen, Ruiqing Sun, Yee-Man Lau, Kwong-Man Ng, Chun-Ka Wong, Hung-Fat Tse und 9 weitere

Antimicrobial Agents and Chemotherapy · 06.08.2025 · 69 (8)

DOI: 10.1128/aac.00024-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 06.08.2025. Verfasst von Xinjie Meng und 20 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Rhinovirus, Antiviral Agents, Virus Internalization, Influenza A Virus, H1N1 Subtype. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global burden of influenza virus and rhinovirus, along with significant mortality and severe case reports, underscores the urgent need for new antivirals. Human defensins serve as the first line of defense against viruses; however, the antiviral activity of defensin peptides is often sensitive to salt, which affects their effectiveness. This study investigates a branched human-defensin peptide H30 (4H30) that can more effectively inhibit influenza virus and rhinovirus compared to the linear form of H30. Mechanistic studies reveal that 4H30 binds to influenza HA to aggregate the virus, thereby blocking viral entry. 4H30 can also cross-link H1N1 virus with cell surface glycosaminoglycans to prevent viral release. The dual-functional peptide 4H30 protects mice from the lethal challenge of the A(H1N1)pdm09 virus, demonstrating a high barrier to viral resistance after 15 viral-culture passages in the presence of 4H30. Notably, 4H30 interferes with the low-density lipoprotein receptor (LDLR) to impede the entry of minor group rhinovirus and significantly inhibits rhinovirus replication in RD cells, nasal organoids, and stem cell-derived cardiomyocytes. These findings suggest that the branched peptide 4H30, targeting both the virus and host, can more effectively inhibit influenza and rhinovirus than the linear H30, providing a new avenue for antiviral peptide development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RhinovirusAntiviral AgentsVirus InternalizationInfluenza A Virus, H1N1 SubtypeDefensinsPeptidesAnimalsHumansMiceVirus ReplicationMice, Inbred BALB CDogsMadin Darby Canine Kidney CellsFemaleOrthomyxoviridae InfectionsInfluenza, Human

Stichwörter der Autor:innen

antiviral peptidehuman defensin peptideinfluenza virusrhinovirusviral entry

Substanzen

Antiviral AgentsDefensinsPeptides

Autor:innen und Institutionen

  • Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China.
  • Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong, China.
  • State Key Laboratory for Emerging Infectious Diseases, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
  • Cardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong, China.
  • Pandemic Research Alliance Unit at The University of Hong Kong, The University of Hong Kong, Hong Kong, China.
  • Carol Yu Centre for Infection, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

ORCID-Profile: Shibo Jiang, Kelvin Kai-Wang To, Kwok-Yung Yuen, Hanjun Zhao

Zitieren

APA

Meng, X., Zhang, C., Wang, X., Shi, J., Song, Z., Ke, P., Chen, Y., Sun, R., Lau, Y. M., Ng, K. M., Wong, C. K., Tse, H. F., Chen, L., Chan, K. H., Yip, C. C. Y., Zhou, J., Xie, Y., Jiang, S., To, K. K. W., …, & Zhao, H. (2025). A branched peptide targets virus and host to block influenza virus and rhinovirus entry. Antimicrobial Agents and Chemotherapy, 69(8). https://doi.org/10.1128/aac.00024-25

Vancouver

Meng X, Zhang C, Wang X, Shi J, Song Z, Ke P, et al. A branched peptide targets virus and host to block influenza virus and rhinovirus entry. Antimicrobial Agents and Chemotherapy. 2025;69(8). doi:10.1128/aac.00024-25

BibTeX
@article{Meng2025,
  author = {Meng, Xinjie and Zhang, Chuyuan and Wang, Xiankun and Shi, Jilong and Song, Zixian and Ke, Purui and Chen, Yao and Sun, Ruiqing and Lau, Yee-Man and Ng, Kwong-Man and Wong, Chun-Ka and Tse, Hung-Fat and Chen, Linlei and Chan, Kwok Hung and Yip, Cyril Chik-Yan and Zhou, Jie and Xie, Youhua and Jiang, Shibo and To, Kelvin Kai-Wang and Yuen, Kwok-Yung and Zhao, Hanjun},
  title = {A branched peptide targets virus and host to block influenza virus and rhinovirus entry},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  volume = {69},
  number = {8},
  doi = {10.1128/aac.00024-25}
}
Kostenlos starten →